SEMA3F also induces formation of NRP2–PLXNA1 complex, which recruits ABL2 and p190 to inactivate RhoA, inhibiting cell migration and contractility of U87 MG glioma cells (34). The gene discussed is NRP2; the disease is central nervous system cancer.